Stay tuned for our LIVE OncLive News Network coverage straight from the #ASH18 conference floor! 

Dr. Khorana on Blood Clots in Patients with Cancer

Alok A. Khorana, MD
Published: Monday, Jun 15, 2015



Alok Khorana, MD, medical oncologist, Cleveland Clinic, discusses blood clot risk and treatment for patients with cancer.

On average, one-fifth of patients with cancer will experience a blood clot, says Khorana. For years, the standard of care for treating blood clots in cancer patients was low molecular weight heparins. More recently, direct oral anticoagulants have become common for the treatment of blood clots.

However, there have been no cancer patient-specific studies evaluating these new agents. Patients' absorption is different and they may have different interactions to these blood clots therapies than non-cancer therapies, says Khorana. In a collaboration with Janssen Pharmaceuticals, Cleveland Clinic is investigating these new agents in a cancer patient-specific trial.
 


Alok Khorana, MD, medical oncologist, Cleveland Clinic, discusses blood clot risk and treatment for patients with cancer.

On average, one-fifth of patients with cancer will experience a blood clot, says Khorana. For years, the standard of care for treating blood clots in cancer patients was low molecular weight heparins. More recently, direct oral anticoagulants have become common for the treatment of blood clots.

However, there have been no cancer patient-specific studies evaluating these new agents. Patients' absorption is different and they may have different interactions to these blood clots therapies than non-cancer therapies, says Khorana. In a collaboration with Janssen Pharmaceuticals, Cleveland Clinic is investigating these new agents in a cancer patient-specific trial.
 



View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Community Practice Connections™: Oncology Best Practice™ Decision Points in Advanced NSCLC: Assessing Treatment Options Beyond Disease ProgressionNov 30, 20181.0
Community Practice Connections™: Precision Medicine for Community Oncologists: Assessing the Role of Tumor-Testing Technologies in Cancer CareNov 30, 20181.0
Publication Bottom Border
Border Publication
x